NeoGenomics (MEX:NEO) Interest Expense: MXN-50 Mil (TTM As of Mar. 2026)

What is NeoGenomics Interest Expense?

NeoGenomics MEX:NEO 62 Interest Expense is MXN-50 Mil as of Mar. 2026. GuruFocus rates MEX:NEO with a GF Score™ of 62/100 and a GF Value™ of MXN477.80 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. NeoGenomics's interest expense for the three months ended in Mar. 2026 was MXN -11 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-50 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. NeoGenomics's Operating Income for the three months ended in Mar. 2026 was MXN -329 Mil. NeoGenomics's Interest Expense for the three months ended in Mar. 2026 was MXN -11 Mil. NeoGenomics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NeoGenomics (MEX:NEO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NeoGenomics's Interest Expense for the three months ended in Mar. 2026 was MXN-11 Mil. Its Operating Income for the three months ended in Mar. 2026 was MXN-329 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was MXN7,280 Mil.

NeoGenomics's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

NeoGenomics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

NeoGenomics Interest Expense Historical Data

* Premium members only.

The historical data trend for NeoGenomics's Interest Expense can be seen below:

NeoGenomics Interest Expense Chart

NeoGenomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-168.63

-147.80

-117.24

-138.00

-67.58

NeoGenomics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-33.10	-17.57	-11.06	-10.79	-10.78

62GF Score

NeoGenomics Inc MEX:NEO

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

NeoGenomics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-50 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of MXN-50 Mil mean?

NeoGenomics (MEX:NEO) has a Interest Expense of MXN-50 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on NeoGenomics and its competitors.

Is NeoGenomics' Interest Expense too high?

NeoGenomics' current Interest Expense is MXN-50 Mil. Overall, NeoGenomics has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does NeoGenomics' Interest Expense compare to WGS and CDNA?

NeoGenomics' Interest Expense of MXN-50 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Diagnostics & Research company?

A good Interest Expense depends on the Medical Diagnostics & Research industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on NeoGenomics and its competitors. NeoGenomics's current Interest Expense is MXN-50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is NeoGenomics stock overvalued right now?

Based on GuruFocus' analysis, NeoGenomics (MEX:NEO) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN477.80, compared to a current price of MXN176.40 — trading 63.1% below its estimated fair value. The current Interest Expense is MXN-50 Mil. NeoGenomics' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For NeoGenomics (MEX:NEO), the current Interest Expense is MXN-50 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeoGenomics (MEX:NEO) Overvalued in 2026?

Based on GuruFocus' analysis, NeoGenomics stock appears to be undervalued. The current stock price of MXN176.40 is trading 63.1% below its estimated GF Value™ of MXN477.80. GuruFocus considers NeoGenomics to be Significantly Undervalued.

Key valuation signals for MEX:NEO:

Interest Expense: MXN-50 Mil
GF Value™: MXN477.80 vs. price of MXN176.40 (63.1% below fair value)
GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the MEX:NEO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeoGenomics Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies WGS CDNA PSNL OPK GRAL CSTL FLGT MYGN ADPT BDSX TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN

Other Exchanges NEO:USA NG9:Germany

Address 9490 NeoGenomics Way, Fort Myers, FL, USA, 33912

Website https://www.neogenomics.com

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

62GF Score

Get the complete analysis for MEX:NEO

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN176.40

Price

MXN477.80

GF Value

View MEX:NEO Analysis

See Interest Expense data for all stocks →